These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38004636)

  • 21. Epstein-barr virus latent membrane protein-1 mediates upregulation of tumor necrosis factor-alpha in EBV-infected T cells: implications for the pathogenesis of hemophagocytic syndrome.
    Lay JD; Chuang SE; Rowe M; Su IJ
    J Biomed Sci; 2003; 10(1):146-55. PubMed ID: 12607539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Disorders Manifested as Gastrointestinal Perforations and Skin Lesions: A Case Report.
    Xiao HJ; Li J; Song HM; Li ZH; Dong M; Zhou XG
    Medicine (Baltimore); 2016 Feb; 95(5):e2676. PubMed ID: 26844502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
    Wang F; Tsang SF; Kurilla MG; Cohen JI; Kieff E
    J Virol; 1990 Jul; 64(7):3407-16. PubMed ID: 2352328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of Epstein-Barr virus (EBV)-encoded latent membrane protein (LMP)-1 in the potentiation of C epsilon mRNA expression in human tonsil-derived cells.
    Ohta S; Hanashiro K; Sunagawa M; Tono T; Suzuki M; Kosugi T
    Eur Arch Otorhinolaryngol; 2007 Mar; 264(3):245-50. PubMed ID: 17089136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines.
    Kis LL; Takahara M; Nagy N; Klein G; Klein E
    Blood; 2006 Apr; 107(7):2928-35. PubMed ID: 16332968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development.
    Arai A
    Front Pediatr; 2019; 7():14. PubMed ID: 30805320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
    Chiang AK; Tao Q; Srivastava G; Ho FC
    Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells.
    Noguchi T; Ikeda K; Yamamoto K; Yoshida I; Ashiba A; Tsuchiyama J; Shinagawa K; Yoshino T; Takata M; Harada M
    Br J Haematol; 2001 Jul; 114(1):84-92. PubMed ID: 11472349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
    Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G
    J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.
    Kasahara Y; Yachie A; Takei K; Kanegane C; Okada K; Ohta K; Seki H; Igarashi N; Maruhashi K; Katayama K; Katoh E; Terao G; Sakiyama Y; Koizumi S
    Blood; 2001 Sep; 98(6):1882-8. PubMed ID: 11535525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells.
    Isobe Y; Sugimoto K; Yang L; Tamayose K; Egashira M; Kaneko T; Takada K; Oshimi K
    Cancer Res; 2004 Mar; 64(6):2167-74. PubMed ID: 15026359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
    Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD137 expression is induced by Epstein-Barr virus infection through LMP1 in T or NK cells and mediates survival promoting signals.
    Yoshimori M; Imadome K; Komatsu H; Wang L; Saitoh Y; Yamaoka S; Fukuda T; Kurata M; Koyama T; Shimizu N; Fujiwara S; Miura O; Arai A
    PLoS One; 2014; 9(11):e112564. PubMed ID: 25409517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.
    Oyoshi MK; Nagata H; Kimura N; Zhang Y; Demachi A; Hara T; Kanegane H; Matsuo Y; Yamaguchi T; Morio T; Hirano A; Shimizu N; Yamamoto K
    Am J Pathol; 2003 May; 162(5):1629-38. PubMed ID: 12707047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and genetic characterization of Epstein-Barr virus-associated T/NK-cell lymphoproliferative diseases.
    Luo H; Liu D; Liu W; Jin J; Bi X; Zhang P; Gu J; Zheng M; Xiao M; Liu X; Zhou J; Wang QF
    J Allergy Clin Immunol; 2023 Apr; 151(4):1096-1109. PubMed ID: 36423698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 and B-Cell Growth Transformation Induce Lipogenesis through Fatty Acid Synthase.
    Hulse M; Johnson SM; Boyle S; Caruso LB; Tempera I
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33208446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas.
    Takacs M; Segesdi J; Banati F; Koroknai A; Wolf H; Niller HH; Minarovits J
    Mediterr J Hematol Infect Dis; 2009 Nov; 1(2):e2009012. PubMed ID: 21416002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of MicroRNA Cluster miR-183-96-182 Expression by Epstein-Barr Virus Latent Membrane Protein 1.
    Oussaief L; Fendri A; Chane-Woon-Ming B; Poirey R; Delecluse HJ; Joab I; Pfeffer S
    J Virol; 2015 Dec; 89(23):12178-88. PubMed ID: 26401047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
    Yachie A; Kanegane H; Kasahara Y
    Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.